Appeals and Effective Appellate Advocacy
About This Course
This course discusses appeals and how to be an effective appellate advocate. The course is designed for lawyers who have litigated primarily in trial courts, rather than focusing on appeals.
Advocacy before the appeals court differs from advocacy before the trial court because it requires seeing the world through the eyes of the appellate judge. As former Chief Judge Michel of the Federal Circuit has written, “An appeals court mainly corrects repeatable legal error, not individual mistaken results.” This process requires consideration of the standard of review and the body of information in the appeal record more than how the witnesses testified and what the individual documents say.
About the Presenters
Jennifer Wu, Esq.
Paul, Weiss, Rifkind, Wharton & Garrison LLP
Practice Area: Trial
A partner in the Litigation Department, Jennifer H. Wu focuses her practice on patent litigation matters. Jennifer frequently tries cases in federal district courts and the International Trade Commission. She also argues appeals in the U.S. Court of Appeals for the Federal Circuit and represents clients in the U.S. Supreme Court. She has litigated patents in various technical areas, including sequencing technology and GPS devices, emphasizing biotechnology. Jennifer’s work on biologics includes litigating issues of first impression as to the BPCIA.Jennifer clerked for Judge Alan D. Lourie at the U.S. Court of Appeals for the Federal Circuit. She is an ...
View DetailsLaura Lydigsen, Esq.
Crowell & Moring LLP
Practice Area: Intellectual Property
Laura A Lydigsen is a co-chair of Crowell & Moring's Patent and ITC Litigation Group. Her practice includes intellectual property litigation at both the district court and appellate level, with an emphasis on pharmaceuticals, biotechnology, and medical devices.Laura has extensive experience in representing generic pharmaceutical companies in Hatch-Waxman pharmaceutical litigation. She has appeared in litigations and/or Patent Trial and Appeal Board (PTAB) proceedings involving over two dozen different drug products and assisted clients with regulatory and pre-litigation strategy for many other drug products. She recognizes that a winning strategy in pharmaceutical litigation must be paired with good regulatory and business ...
View Details